T Cell Therapy Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application
- Report Code : PRO2581835
- Published On: Jun, 2021
- Category : Pharmaceuticals
- Pages : 20
-
This report describes the global market size of T Cell Therapy from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.
For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of T Cell Therapy as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share
Types Segment:
Autologous T cell therapy
Allogenic T cell therapy
Companies Covered:
Adaptimmune Therapeutics PLC
Amgen Inc.
Autolus Therapeutics PLC
Bluebird Bio
Gilead
Novartis International AG
Celgene
Tmunity Therapeutics
Unum Therapeutics Inc.
Atara Biotherapeutics
Celyad S.A.
CRISPR Therapeutics AG
Fate Therapeutics Inc.
etc.
Please ask for sample pages for full companies list
Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026
Any special requirements about this report, please let us know and we can provide custom report.
-
With tables and figures helping analyze worldwide T Cell Therapy Global market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions3.3 Research Method
Chapter Four Market Landscape4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis6.1 Upstream/Suppliers Analysis
6.2 T Cell Therapy Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast T Cell Therapy Market in North America (2016-2026)8.1 T Cell Therapy Market Size
8.2 T Cell Therapy Market by End Use
8.3 Competition by Players/Suppliers
8.4 T Cell Therapy Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast T Cell Therapy Market in South America (2016-2026)9.1 T Cell Therapy Market Size
9.2 T Cell Therapy Market by End Use
9.3 Competition by Players/Suppliers
9.4 T Cell Therapy Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast T Cell Therapy Market in Asia & Pacific (2016-2026)10.1 T Cell Therapy Market Size
10.2 T Cell Therapy Market by End Use
10.3 Competition by Players/Suppliers
10.4 T Cell Therapy Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast T Cell Therapy Market in Europe (2016-2026)11.1 T Cell Therapy Market Size
11.2 T Cell Therapy Market by End Use
11.3 Competition by Players/Suppliers
11.4 T Cell Therapy Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast T Cell Therapy Market in MEA (2016-2026)12.1 T Cell Therapy Market Size
12.2 T Cell Therapy Market by End Use
12.3 Competition by Players/Suppliers
12.4 T Cell Therapy Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global T Cell Therapy Market (2016-2021)13.1 T Cell Therapy Market Size
13.2 T Cell Therapy Market by End Use
13.3 Competition by Players/Suppliers
13.4 T Cell Therapy Market Size by Type
Chapter 14 Global T Cell Therapy Market Forecast (2021-2026)14.1 T Cell Therapy Market Size Forecast
14.2 T Cell Therapy Application Forecast
14.3 Competition by Players/Suppliers
14.4 T Cell Therapy Type Forecast
Chapter 15 Analysis of Global Key Vendors15.1 Adaptimmune Therapeutics PLC
15.1.1 Company Profile
15.1.2 Main Business and T Cell Therapy Information
15.1.3 SWOT Analysis of Adaptimmune Therapeutics PLC
15.1.4 Adaptimmune Therapeutics PLC T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)15.2 Amgen Inc.
15.2.1 Company Profile
15.2.2 Main Business and T Cell Therapy Information
15.2.3 SWOT Analysis of Amgen Inc.
15.2.4 Amgen Inc. T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)15.3 Autolus Therapeutics PLC
15.3.1 Company Profile
15.3.2 Main Business and T Cell Therapy Information
15.3.3 SWOT Analysis of Autolus Therapeutics PLC
15.3.4 Autolus Therapeutics PLC T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)15.4 Bluebird Bio
15.4.1 Company Profile
15.4.2 Main Business and T Cell Therapy Information
15.4.3 SWOT Analysis of Bluebird Bio
15.4.4 Bluebird Bio T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)15.5 Gilead
15.5.1 Company Profile
15.5.2 Main Business and T Cell Therapy Information
15.5.3 SWOT Analysis of Gilead
15.5.4 Gilead T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)15.6 Novartis International AG
15.6.1 Company Profile
15.6.2 Main Business and T Cell Therapy Information
15.6.3 SWOT Analysis of Novartis International AG
15.6.4 Novartis International AG T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
15.7 Celgene
15.7.1 Company Profile
15.7.2 Main Business and T Cell Therapy Information
15.7.3 SWOT Analysis of Celgene
15.7.4 Celgene T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
15.8 Tmunity Therapeutics
15.8.1 Company Profile
15.8.2 Main Business and T Cell Therapy Information
15.8.3 SWOT Analysis of Tmunity Therapeutics
15.8.4 Tmunity Therapeutics T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
15.9 Unum Therapeutics Inc.
15.9.1 Company Profile
15.9.2 Main Business and T Cell Therapy Information
15.9.3 SWOT Analysis of Unum Therapeutics Inc.
15.9.4 Unum Therapeutics Inc. T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)15.10 Atara Biotherapeutics
15.10.1 Company Profile
15.10.2 Main Business and T Cell Therapy Information
15.10.3 SWOT Analysis of Atara Biotherapeutics
15.10.4 Atara Biotherapeutics T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
15.11 Celyad S.A.
15.11.1 Company Profile
15.11.2 Main Business and T Cell Therapy Information
15.11.3 SWOT Analysis of Celyad S.A.
15.11.4 Celyad S.A. T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
15.12 CRISPR Therapeutics AG
15.12.1 Company Profile
15.12.2 Main Business and T Cell Therapy Information
15.12.3 SWOT Analysis of CRISPR Therapeutics AG
15.12.4 CRISPR Therapeutics AG T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
15.13 Fate Therapeutics Inc.
15.13.1 Company Profile
15.13.2 Main Business and T Cell Therapy Information
15.13.3 SWOT Analysis of Fate Therapeutics Inc.
15.13.4 Fate Therapeutics Inc. T Cell Therapy Revenue, Gross Margin and Market Share (2016-2021)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of T Cell Therapy Report
Table Data Sources of T Cell Therapy Report
Table Major Assumptions of T Cell Therapy Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure T Cell Therapy Picture
Table T Cell Therapy Classification
Table T Cell Therapy Applications
Table Drivers of T Cell Therapy Market
Table Restraints of T Cell Therapy Market
Table Opportunities of T Cell Therapy Market
Table Threats of T Cell Therapy Market
Table Covid-19 Impact For T Cell Therapy Market
Table Raw Materials Suppliers
Table Different Production Methods of T Cell Therapy
Table Cost Structure Analysis of T Cell Therapy
Table Key End Users
Table Latest News of T Cell Therapy Market
Table Merger and Acquisition
Table Planned/Future Project of T Cell Therapy Market
Table Policy of T Cell Therapy Market
Table 2016-2026 North America T Cell Therapy Market Size
Figure 2016-2026 North America T Cell Therapy Market Size and CAGR
Table 2016-2026 North America T Cell Therapy Market Size by Application
Table 2016-2021 North America T Cell Therapy Key Players Revenue
Table 2016-2021 North America T Cell Therapy Key Players Market Share
Table 2016-2026 North America T Cell Therapy Market Size by Type
Table 2016-2026 United States T Cell Therapy Market Size
Table 2016-2026 Canada T Cell Therapy Market Size
Table 2016-2026 Mexico T Cell Therapy Market Size
Table 2016-2026 South America T Cell Therapy Market Size
Figure 2016-2026 South America T Cell Therapy Market Size and CAGR
Table 2016-2026 South America T Cell Therapy Market Size by Application
Table 2016-2021 South America T Cell Therapy Key Players Revenue
Table 2016-2021 South America T Cell Therapy Key Players Market Share
Table 2016-2026 South America T Cell Therapy Market Size by Type
Table 2016-2026 Brazil T Cell Therapy Market Size
Table 2016-2026 Argentina T Cell Therapy Market Size
Table 2016-2026 Chile T Cell Therapy Market Size
Table 2016-2026 Peru T Cell Therapy Market Size
Table 2016-2026 Asia & Pacific T Cell Therapy Market Size
Figure 2016-2026 Asia & Pacific T Cell Therapy Market Size and CAGR
Table 2016-2026 Asia & Pacific T Cell Therapy Market Size by Application
Table 2016-2021 Asia & Pacific T Cell Therapy Key Players Revenue
Table 2016-2021 Asia & Pacific T Cell Therapy Key Players Market Share
Table 2016-2026 Asia & Pacific T Cell Therapy Market Size by Type
Table 2016-2026 China T Cell Therapy Market Size
Table 2016-2026 India T Cell Therapy Market Size
Table 2016-2026 Japan T Cell Therapy Market Size
Table 2016-2026 South Korea T Cell Therapy Market Size
Table 2016-2026 Southeast Asia T Cell Therapy Market Size
Table 2016-2026 Australia T Cell Therapy Market Size
Table 2016-2026 Europe T Cell Therapy Market Size
Figure 2016-2026 Europe T Cell Therapy Market Size and CAGR
Table 2016-2026 Europe T Cell Therapy Market Size by Application
Table 2016-2021 Europe T Cell Therapy Key Players Revenue
Table 2016-2021 Europe T Cell Therapy Key Players Market Share
Table 2016-2026 Europe T Cell Therapy Market Size by Type
Table 2016-2026 Germany T Cell Therapy Market Size
Table 2016-2026 France T Cell Therapy Market Size
Table 2016-2026 United Kingdom T Cell Therapy Market Size
Table 2016-2026 Italy T Cell Therapy Market Size
Table 2016-2026 Spain T Cell Therapy Market Size
Table 2016-2026 Belgium T Cell Therapy Market Size
Table 2016-2026 Netherlands T Cell Therapy Market Size
Table 2016-2026 Austria T Cell Therapy Market Size
Table 2016-2026 Poland T Cell Therapy Market Size
Table 2016-2026 Russia T Cell Therapy Market Size
Table 2016-2026 MEA T Cell Therapy Market Size
Figure 2016-2026 MEA T Cell Therapy Market Size and CAGR
Table 2016-2026 MEA T Cell Therapy Market Size by Application
Table 2016-2021 MEA T Cell Therapy Key Players Revenue
Table 2016-2021 MEA T Cell Therapy Key Players Market Share
Table 2016-2026 MEA T Cell Therapy Market Size by Type
Table 2016-2026 Egypt T Cell Therapy Market Size
Table 2016-2026 Israel T Cell Therapy Market Size
Table 2016-2026 South Africa T Cell Therapy Market Size
Table 2016-2026 Gulf Cooperation Council Countries T Cell Therapy Market Size
Table 2016-2026 Turkey T Cell Therapy Market Size
Table 2016-2021 Global T Cell Therapy Market Size by Region
Table 2016-2021 Global T Cell Therapy Market Size Share by Region
Table 2016-2021 Global T Cell Therapy Market Size by Application
Table 2016-2021 Global T Cell Therapy Market Share by Application
Table 2016-2021 Global T Cell Therapy Key Vendors Revenue
Figure 2016-2021 Global T Cell Therapy Market Size and Growth Rate
Table 2016-2021 Global T Cell Therapy Key Vendors Market Share
Table 2016-2021 Global T Cell Therapy Market Size by Type
Table 2016-2021 Global T Cell Therapy Market Share by Type
Table 2021-2026 Global T Cell Therapy Market Size by Region
Table 2021-2026 Global T Cell Therapy Market Size Share by Region
Table 2021-2026 Global T Cell Therapy Market Size by Application
Table 2021-2026 Global T Cell Therapy Market Share by Application
Table 2021-2026 Global T Cell Therapy Key Vendors Revenue
Figure 2021-2026 Global T Cell Therapy Market Size and Growth Rate
Table 2021-2026 Global T Cell Therapy Key Vendors Market Share
Table 2021-2026 Global T Cell Therapy Market Size by Type
Table 2021-2026 T Cell Therapy Global Market Share by Type
-
The T Cell Therapy Global Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
In 2023, the T Cell Therapy Global Market share exceeded USD xx million. Between 2024 and 2029, it will grow at a CAGR of yy%.
As the shift to value addition continues, companies in the T Cell Therapy Global Market face the dual challenge of improving interoperability to optimize performance and experience.
The majority of data for the T Cell Therapy Global Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.